Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Senator Questions Abbott Recall Of Baby Formula
Pharmalot
Monday, September 27, 2010 - 10:50am
tags:
infant formula, Abbott Laboratories, recalls
Seattle Genetics, Takeda Drug Shrinks Lymphoma Patients' Tumors in Study
Bloomberg
Monday, September 27, 2010 - 10:47am
tags:
Seattle Genetics, Takeda, lymphoma, Hodgkin's lymphoma
Santarus: Building a New Company on Zegerid’s Ashes
Seeking Alpha
Monday, September 27, 2010 - 10:45am
tags:
Zegerid, Santarus, generics
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Monday, September 27, 2010 - 10:43am
tags:
obesity, Vivus, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
Theravance in Neutral Lane
Yahoo/Zacks.com
Monday, September 27, 2010 - 10:41am
tags:
Theravance, Vibativ, GSK
AstraZeneca Prostate Cancer Drug Fails
TheStreet.com
Monday, September 27, 2010 - 10:40am
tags:
prostate cancer, AstraZeneca, zibotentan, Dendreon, Provenge
Another Setback for Roche's Cancer Drug
Seeking Alpha
Sunday, September 26, 2010 - 12:47pm
tags:
Roche, Avastin, colon cancer
Private Biotechs Take Different Avenues to Rake in Cash
Seeking Alpha
Sunday, September 26, 2010 - 12:45pm
tags:
Reata, Abbott Laboratories, Bardoxolone, chronic kidney disease, Asthmatx, Boston Scientific, CytomX, Emergent BioSolutions
GSK's Diabetes Pill: Lessons Learned, Unanswered Questions
Seeking Alpha
Sunday, September 26, 2010 - 12:28pm
tags:
GSK, Avandia, diabetes
$93,000 cancer drug: How much is a life worth?
Yahoo/AP
Sunday, September 26, 2010 - 12:27pm
tags:
Provenge, Dendreon, Revlimid, Celgene
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sunday, September 26, 2010 - 12:24pm
tags:
Novartis, Merck KGaA, Gilenya, multiple sclerosis, cladribine, Biogen Idec, Bayer, Teva Pharmaceuticals
Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
Seeking Alpha
Sunday, September 26, 2010 - 12:22pm
tags:
Qnexa, Vivus, obesity
Diabetes Therapeutic Market Reached $24.9 Billion in 2009
PR-USA.net
Saturday, September 25, 2010 - 1:13pm
tags:
diabetes
Merck considers appeal of MS drug rejection
Financial Times, UK
Saturday, September 25, 2010 - 1:11pm
tags:
Merck, multiple sclerosis, cladribine
Lundbeck Launches New Research And Development Strategy
Medical News Today
Saturday, September 25, 2010 - 1:09pm
tags:
Lundbeck
Eli Lilly and Company Encourages African-Americans to Get a Check-up and Face Diabetes
Trading Markets
Saturday, September 25, 2010 - 1:07pm
tags:
Eli Lilly, diabetes
Dynavax Technologies Corp commences Phase 1b trial for Universal Flu Vaccine
Trading Markets
Saturday, September 25, 2010 - 1:05pm
tags:
Dynavax, flu vaccine, vaccines
Prepare for This $12 Billion Whoosh (Lipitor Generic)
Motley Fool
Saturday, September 25, 2010 - 12:16pm
tags:
Pfizer, Lipitor, AstraZeneca, Crestor, Merck, Zocor
Priority Review for AZN Drug
Yahoo/Zacks
Saturday, September 25, 2010 - 12:14pm
tags:
AstraZeneca, vandetanib, thyroid cancer
AstraZeneca, Bristol Myers Move Forward With Diabetes Drug
Minyanville
Saturday, September 25, 2010 - 12:11pm
tags:
AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.